Europe Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

List of Tables

The Europe antimicrobial surgical suture market size is expected to reach US$ 252.11 million by 2031 from US$ 119.72 million in 2023. The market is estimated to record a CAGR of 9.8% from 2024-2031.

Executive Summary and Europe Antimicrobial Surgical Suture Market Analysis:

The Europe antimicrobial surgical suture market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Europe occupies the second position in the global antimicrobial surgical suture market and is expected to register a robust growth rate over the forecast period. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in cardiovascular surgeries, general surgeries, and orthopedic surgeries is leading to market growth.

Europe Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the Europe antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the Europe antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the Europe antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the Europe antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

Europe Antimicrobial Surgical Suture Market Outlook

Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.

Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.

Europe Antimicrobial Surgical Suture Market Country Insights

Based on country, the Europe antimicrobial surgical suture market comprises Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.

The increasing demand for infection prevention and control measures in healthcare settings is a primary market driver, owing to the rising incidence of surgical site infections (SSIs) and antibiotic-resistant bacteria. Data from a recent study published in Research Article by Avidicare indicate that despite stringent laws and guidelines, surgical site infections (SSIs) in Germany did not decline between 2008 and 2016. Based on real hospital reimbursement data from 4 million patients, the study period's total SSI prevalence was 4.9%. The researchers conclude that the actual number of SSIs has been greatly underestimated compared to the self-reported 1.08% SSI rates for German hospitals based on the voluntary Krankenhaus-Infektions-Surveillance-System.

The growing awareness among healthcare professionals about the benefits of antimicrobial sutures in reducing SSIs and improving patient outcomes is contributing to the adoption of these sutures. Favorable reimbursement policies and high healthcare expenditure in Germany also enable hospitals and clinics to adopt advanced suturing technologies. The country's well-established healthcare system and many annual surgical procedures create a high demand for antimicrobial sutures. Furthermore, stringent regulatory frameworks and guidelines for infection control are driving the adoption of antimicrobial sutures as a standard of care. Ongoing research and development activities by companies in the country are leading to the introduction of innovative antimicrobial suture products, further fueling market growth.

Europe Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include TI Medical; Healthium Medtech Limited; Meril Life Sciences Pvt Ltd; Unilene; Johnson & Johnson; Futura Surgicare Pvt Ltd (Dolphin Sutures); Cencora, Inc. (AmerisourceBergen Corporation); Advanced MedTech Solutions Pvt. Ltd.; and Internacional Farmaceutica SA among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Product Code: BMIRE00031798

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Antimicrobial Surgical Suture Market - Key Market Dynamics

4.1 Market Drivers:
- 4.1.1 Surging Prevalence of Surgical Site Infections
- 4.1.2 Increasing Cases of Chronic Wounds and Surgeries
4.2 Market Restraints
- 4.2.1 Non-invasive Alternatives to Stitches
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
4.4 Future Trends
- 4.4.1 Smart Antimicrobial Sutures
4.5 Impact of Drivers and Restraints:

5. Antimicrobial Surgical Suture Market - Europe Analysis

5.1 Europe Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
5.2 Europe Antimicrobial Surgical Suture Market Forecast Analysis

6. Europe Antimicrobial Surgical Suture Market Analysis - by Type

6.1 Triclosan Antimicrobial Suture
- 6.1.1 Overview
- 6.1.2 Triclosan Antimicrobial Suture: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Chlorhexidine Antimicrobial Suture
- 6.2.1 Overview
- 6.2.2 Chlorhexidine Antimicrobial Suture: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Antimicrobial Surgical Suture Market Analysis - by Raw Materials

7.1 Polyglactin 910 Antimicrobial Suture
- 7.1.1 Overview
- 7.1.2 Polyglactin 910 Antimicrobial Suture: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Poliglecaprone 25
- 7.2.1 Overview
- 7.2.2 Poliglecaprone 25: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Polyglycolic Acid
- 7.3.1 Overview
- 7.3.2 Polyglycolic Acid: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Antimicrobial Surgical Suture Market Analysis - by Application

8.1 Cardiovascular Surgery
- 8.1.1 Overview
- 8.1.2 Cardiovascular Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.2 General Surgery
- 8.2.1 Overview
- 8.2.2 General Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Ophthalmic Surgery
- 8.3.1 Overview
- 8.3.2 Ophthalmic Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Gynaecological Surgery
- 8.4.1 Overview
- 8.4.2 Gynaecological Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Orthopedic Surgery
- 8.5.1 Overview
- 8.5.2 Orthopedic Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Plastic Surgery
- 8.6.1 Overview
- 8.6.2 Plastic Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Veterinary Surgery
- 8.7.1 Overview
- 8.7.2 Veterinary Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Dental Surgery
- 8.8.1 Overview
- 8.8.2 Dental Surgery: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Antimicrobial Surgical Suture Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Antimicrobial Surgical Suture Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Antimicrobial Surgical Suture Market Overview
- 10.1.2 Europe Antimicrobial Surgical Suture Market - Breakdown, by Key Countries, 2023 and 2031 (%)
  - 10.1.2.1 Germany: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 Germany: Europe Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.1.2 Germany: Europe Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.1.3 Germany: Europe Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.1.4 Germany: Europe Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.2 France: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 France: Europe Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.2.2 France: Europe Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.2.3 France: Europe Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.2.4 France: Europe Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.3 United Kingdom: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 United Kingdom: Europe Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.3.2 United Kingdom: Europe Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.3.3 United Kingdom: Europe Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.3.4 United Kingdom: Europe Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.4 Italy: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Italy: Europe Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.4.2 Italy: Europe Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.4.3 Italy: Europe Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.4.4 Italy: Europe Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.5 Spain: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.5.1 Spain: Europe Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.5.2 Spain: Europe Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.5.3 Spain: Europe Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.5.4 Spain: Europe Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.6 Rest of Europe: Europe Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.6.1 Rest of Europe: Europe Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.6.2 Rest of Europe: Europe Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.6.3 Rest of Europe: Europe Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.6.4 Rest of Europe: Europe Antimicrobial Surgical Suture Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies
- 11.2.1 Overview
11.3 Company Market Share Analysis (%), 2023

12. Company Profiles

12.1 TI Medical
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Healthium Medtech Limited
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Meril Life Sciences Pvt Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Unilene
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Johnson & Johnson
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Futura Surgicare Pvt Ltd (Dolphin Sutures)
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Cencora, Inc. (AmerisourceBergen Corporation)
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Advanced MedTech Solutions Pvt. Ltd.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Internacional Farmaceutica SA
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms